4.4 Review

Nanodrug applications in photodynamic therapy

Journal

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
Volume 8, Issue 1, Pages 14-29

Publisher

ELSEVIER
DOI: 10.1016/j.pdpdt.2010.12.001

Keywords

Photodynamic therapy; Photosensitizers; Nanomedicine; Nanoparticles; Pharmaceutical nanocarriers; Drug delivery; Drug-conjugates

Categories

Funding

  1. Science Foundation Ireland (SFI) [04/RP1/B482, SFI P.I. 09/IN.1/B2650, SFI SRC 07/SRC/B1154]
  2. Health Research Board (HRB) [2007 TRA/2007/11]

Ask authors/readers for more resources

Photodynamic therapy (PDT) has developed over last century and is now becoming a more widely used medical tool having gained regulatory approval for the treatment of various diseases such as cancer and macular degeneration. It is a two-step technique in which the delivery of a photosensitizing drug is followed by the irradiation of light. Activated photosensitizers transfer energy to molecular oxygen which results in the generation of reactive oxygen species which in turn cause cells apoptosis or necrosis. Although this modality has significantly improved the quality of life and survival time for many cancer patients it still offers significant potential for further improvement. In addition to the development of new PDT drugs, the use of nanosized carriers for photosensitizers is a promising approach which might improve the efficiency of photodynamic activity and which can overcome many side effects associated with classic photodynamic therapy. This review aims at highlighting the different types of nanomedical approaches currently used in PDT and outlines future trends and limitations of nanodelivery of photosensitizers. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available